Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Frequently asked questions
What sector does Schrödinger, Inc (SDGR) operate in?
Schrödinger, Inc belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Schrödinger, Inc (SDGR) current stock price?
As of the latest data, Schrödinger, Inc stock price is $18.46, with a previous close of $18.63. Schrödinger, Inc lost -$0.17 in the last trading session, representing a -0.91% loss.
What is Schrödinger, Inc (SDGR) current market capitalization?
Schrödinger, Inc market cap is approximately 1.21 billion.
What is Schrödinger, Inc (SDGR) Earnings Per Share (EPS)?
The trailing EPS is -$1.52, and the forward EPS is -$1.35.
What is Schrödinger, Inc (SDGR) EBITDA?
Schrödinger, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 7.35 million.
Does Schrödinger, Inc (SDGR) pay dividends?
No. Schrödinger, Inc does not pay a dividend.
How did Schrödinger, Inc (SDGR) perform in its most recent earnings report?
In the last report (June 30, 2026), Schrödinger, Inc posted an EPS surprise of 113.33% and a revenue surprise of 24.65%.
What is Schrödinger, Inc (SDGR) beta (volatility) score?
Schrödinger, Inc has a beta of 1.658, suggesting it is more volatile than the market.
